New

Chrome Plugin Live! Redefine the way you read FinTwit šŸš€ Install Now

You have successfully sign out
Loading...
Shape
CureVac N.V.
CVAC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

617M

Biotechnology

Next Earning date - 12 Nov 2024

617M

Biotechnology

Next Earning date - 12 Nov 2024

2.75USD
Shape0.03Ā ( 1.10%)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

56%

Quote Panel

Shape
Updated October 27, 2024
1W -0.72 % 1M -6.46 % 3M -25.07 % 1Y -46.39 %

Key Metrics

Shape
  • Market Cap

    616.84M


  • Shares Outstanding

    224.31M


  • Share in Float

    93.63M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    2.75


  • Average Volume

    485814


  • Beta

    2.613


  • Range

    2.215-6.3


  • Industry

    Biotechnology


  • Website

    https://www.curevac.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

8.74x

P/S Ratio

1.52x

P/B Ratio

0.1

Debt/Equity

-423.2%

Net Margin

$-1.4

EPS

How CVAC compares to sector?

P/E Ratio

Relative Strength

Shape

CVAC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$57M

Shape291%

2025-Revenue

$0.41

Shape-24%

2025-EPS

$57M

Shape18%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2023-01-07

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.25
vsĀ -0.01

Q4.22

arrow
arrow

N/A

NA
vsĀ NA

Q1.23

arrow
arrow

N/A

-0.60
vsĀ -0.09

Q2.23

arrow
arrow

N/A

-0.33
vsĀ -0.31

Q3.23

arrow
arrow

N/A

-0.24
vsĀ -0.25

Q4.23

arrow
arrow

N/A

NA
vsĀ NA

Q1.24

arrow
arrow

N/A

-0.42
vsĀ -0.60

Q2.24

arrow
arrow

N/A

-0.34
vsĀ -0.33

Q3.24

arrow
arrow

+686%

1.41
vsĀ -0.24

Q4.24

arrow
arrow

N/A

-0.29
vsĀ NA

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-62%

11.2MĀ  vsĀ 29.3M

Q4.22

arrow
arrow

-72%

11.7MĀ  vsĀ 41.2M

Q1.23

arrow
arrow

-71%

7.1MĀ  vsĀ 24.4M

Q2.23

arrow
arrow

-62%

7.6MĀ  vsĀ 20.1M

Q3.23

arrow
arrow

+47%

16.5MĀ  vsĀ 11.2M

Q4.23

arrow
arrow

+88%

22MĀ  vsĀ 11.7M

Q1.24

arrow
arrow

+74%

12.4MĀ  vsĀ 7.1M

Q2.24

arrow
arrow

+91%

14.5MĀ  vsĀ 7.6M

Q3.24

arrow
arrow

-80%

3.3MĀ  vsĀ 16.5M

Q4.24

arrow
arrow

-60%

8.8MĀ  vsĀ 22M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vsĀ -0.09

Q4.22

arrow
arrow

-24%

-0.24
vsĀ -0.08

Q1.23

arrow
arrow

-8%

-0.08
vsĀ -0.24

Q2.23

arrow
arrow

-10%

-0.10
vsĀ -0.08

Q3.23

arrow
arrow

-8%

-0.08
vsĀ -0.10

Q4.23

arrow
arrow

-16%

-0.16
vsĀ -0.08

Q1.24

arrow
arrow

-16%

-0.16
vsĀ -0.16

Q2.24

arrow
arrow

-19%

-0.19
vsĀ -0.16

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

89

89
vsĀ 97

-8%

Q4.22

arrow
arrow

93

93
vsĀ 89

4%

Q1.23

arrow
arrow

88

88
vsĀ 93

-5%

Q2.23

arrow
arrow

93

93
vsĀ 88

6%

Q3.23

arrow
arrow

91

91
vsĀ 93

-2%

Q4.23

arrow
arrow

98

98
vsĀ 91

8%

Q1.24

arrow
arrow

92

92
vsĀ 98

-6%

Q2.24

arrow
arrow

90

90
vsĀ 92

-2%

Earnings Growth

Latest News